New York-based private equity firm Avista Capital Partners seems to be on a holiday shopping spree in Massachusetts–last week it acquired two Boston Scientific business units, and today it announced it’s picking up the Billerica, MA-based medical imaging division of Bristol-Myers Squibb (NYSE: [[ticker:BMY]]) for some $525 million. The deal is expected to close by the end of January.
Author: Rebecca Zacks
Rebecca is Xconomy's co-founder. She was previously the managing editor of Physician's First Watch, a daily e-newsletter from the publishers of New England Journal of Medicine. Before helping launch First Watch, she spent a decade covering innovation for Technology Review, Scientific American, and Discover Magazine's TV show. In 2005-2006 she was a Knight Science Journalism Fellow at MIT. Rebecca holds a bachelor's degree in biology from Brown University and a master's in science journalism from Boston University.
View all posts by Rebecca Zacks
